Selective inhibition of deoxyribonucleic acid synthesis by salicylhydroxamic acid.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D006877:Hydroxamic Acids / Q000494:pharmacology*; D066298:In Vitro Techniques; D009363:Neoplasm Proteins / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012459:Salicylates / Q000494:pharmacology*
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D006877:Hydroxamic Acids; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D012459:Salicylates